TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| Vanda Pharmaceuticals Downgrade: Why I Don't Buy It VFC submits: Vanda Pharmaceuticals (VNDA) received a downgrade from Madison Williams last week to "reduce" from "buy."Analyst David Moskowitz cited a physicians survey conducted by Madison Williams as the reason behind the downgrade, according to publicly released information. The survey of psychiatrists concluded that Novartis (NVS) was doing an "abysmal" job at handling Fanapt's commercial launch, which took place earlier this year.Complete Story » seekingalpha.com |
The Skinny on Arena's Partnership With Japan's Eisai Ruthanne Williams Roussel submits:On July 1 Arena Pharmaceuticals (ARNA) announced a US marketing partnership for its late-stage obesity drug candidate lorcaserin with the US arm of Japan's Eisai, known for gastrointestinal drugs, among others. A well-attended conference call was held before market open, which will be archived on the company's web site for 30 days.Reasonable people may disagree whether this is the long hoped-for partnership with Big Pharma by one of the three small-pharma obesity drug developers, ARNA, Vivus Inc. (VVUS) and Orexigen Therapeutics (OREX), all of whom have drug candidates up for FDA review and approval within the next 6 months. While I personally would think of the top dozen or so companies by worldwide revenues when people say "Big Pharma" -- Pfizer (PFE) , GlaxoSmithKline (GSK), Roche et al. -- Eisai is certainly in or close to the top 20, depending on who's counting and over what period, and a muscular partner.Complete Story » seekingalpha.com |
Momenta Pharma Closes In on Sanofi Aventis With Biogeneric Approval Derek Lowe submits: So we actually had two converging stories on Friday afternoon - the news that Sanofi-Aventis (SNY) is going after Genzyme (GENZ), and the news that tiny Momenta Pharmaceuticals (MNTA) finally got FDA approval for a biogeneric of Lovenox (enoxaparin). . .a big seller for Sanofi-Aventis. I knew something was going on with those folks - I'm close enough in Cambridge that I could hear them whooping and popping champagne corks. They've got backing from Novartis (NVS), who will actually be making the stuff using Momenta's techniques, but this was make-or-break news for them, and they've been waiting for quite a while to hear it. Meanwhile, Sanofi-Aventis has been hoping just as long that this day wouldn't come.Complete Story » seekingalpha.com |
Patty Loveless' DRIVE4COPD video - Video New drive4copd Ambassador Program Unites Celebrities and Fans in Nationwide Screening Contest feedproxy.google.com |
Health Overhaul Overlooks Retirees Thanks to a little-noticed clause in a 1996 law, retiree-only health plans are exempt from the Patient Protection and Affordable Care Act that went into effect last month. online.wsj.com |